Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 32.00
0.00 (0.00%)
Jul 14, 2026, 1:14 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.04 billion as of July 14, 2026. Its market cap has decreased by -5.88% in one year.
Market Cap
1.04B
Enterprise Value
823.12M
Revenue
718.58M
Ranking
n/a
PE Ratio
13.56
Stock Price
32.00
Market Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.04B, an increase of 315.93%. That is a compound annual growth rate of 6.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.04B | -3.03% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.18B |
| BiOptic | 1.16B |
| LabTurbo Biotech | 1.11B |
| Lukas Biomedical | 1.07B |
| Bio Preventive Medicine | 1.06B |
| Holy Stone Healthcare | 1.02B |
| U-Neuron Biomedical | 997.31M |
| GeneReach Biotechnology | 979.88M |